Relay Therapeutics, Inc. Business Finance Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement, dated as of January 8, 2024, among Relay Therapeutics, Inc. and the purchaser party thereto
Purchase Agreements
Relay Therapeutics, Inc.
Biotechnology
CA
2024
Underwriting Agreement, dated as of September 12, 2022, by and among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC, as...
Underwriting Agreements
Relay Therapeutics, Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated as of October 12, 2021, by and among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Cowen and Company, LLC and Guggenheim...
Underwriting Agreements
Relay Therapeutics, Inc.
Biotechnology
NY
2021
Registration Rights Agreement by and between the Registrant and the stockholders of ZebiAI Therapeutics, Inc. dated April 22, 2021
Registration Rights Agreements
Relay Therapeutics, Inc.
Biotechnology
DE
2021
2020 Employee Stock Purchase Plan
Stock Agreements
Relay Therapeutics, Inc.
Biotechnology
MA
2020
2020 Stock Option and Grant Plan, and form of award agreements thereunder
Stock Agreements
Relay Therapeutics, Inc.
Biotechnology
MA
2020
Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of December 19, 2018 as amended on June 26, 2020
Investor Rights Agreements
Relay Therapeutics, Inc.
Biotechnology
DE
2020
Specimen Common Stock Certificate
Stock Agreements
Relay Therapeutics, Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Relay Therapeutics, Inc.
Biotechnology
NY
2020
2016 Stock Option and Grant Plan, and form of award agreements thereunder
Stock Agreements
Relay Therapeutics, Inc.
Biotechnology
DE
2020
Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of December 19, 2018
Investor Rights Agreements
Relay Therapeutics, Inc.
Biotechnology
DE
2020